Bradyco Inc’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$892K Hold
5,841
0.69% 25
2025
Q4
$805K Hold
5,841
1% 28
2025
Q3
$749K Sell
5,841
-850
-13% -$104K 0.85% 29
2025
Q2
$707K Hold
6,691
0.52% 39
2025
Q1
$746K Sell
6,691
-500
-7% -$53.2K 0.57% 37
2024
Q4
$700K Buy
+7,191
New +$767K 0.43% 42

Other funds holding NVS

Bradyco Inc's NVS Position: Q1 2026 in Review

Bradyco Inc held its Novartis (NVS) position steady in Q1 2026 at 5,841 shares worth $892K. The position accounts for 0.69% of the portfolio, ranked #25.

Bradyco Inc first reported a position in NVS in Q4 2024 and has held it in 6 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Bradyco Inc held 5,841 shares of Novartis worth $892K as of Q1 2026.
  • Bradyco Inc left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.69% of Bradyco Inc's portfolio in Q1 2026, its #25 holding.
  • Bradyco Inc first reported a position in Novartis in Q4 2024 and has held it in 6 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Bradyco Inc's 13F filing for Q1 2026, filed 13 May 2026.